Fiasp – some further observations… Or why an artificial pancreas can’t do everything!
I’ve written about the various curveballs that Fiasp has thrown at me on multiple occasions, and for the past few weeks I’ve continued to observe […]
Diabetes
Analyzing the output of the continuous monitoring survey – some thoughts on the data… #wearenotwaiting
Earlier this week I published the first set of results of the survey of CGM and Libre users that I undertook last year. There was […]
Port and Portability – some further thoughts. A truly portable, offline instance of #OpenAPS
Late last year, I wrote about form and physicality of the hybrid closed loop, bemoaning the stuff I was carrying, and a few other things. […]
What is the purpose of an “Artificial Pancreas”? It may explain why #wearenotwaiting !
This question seems relatively straightforward to answer. Surely it’s just to provide a way of delivering insulin automatically, leading to less user intervention and making […]
Hybrid Closed Looping with #OpenAPS – eat what you like and no need to worry…. #wearenotwaiting
One of the things that I’ve previously described Closed Looping as is automated sugar surfing, and I’d still stand by that description, especially when you […]
A year of personal progress with Diabetes Technology. Like many others, #wearenotwaiting
2016. One hell of a year, and not always in the right way. But looking at it from my own personal transition on the Diabetes […]
#Loop and #OpenAPS – living with both, the similarities and differences – let’s get down and dirty…
This post has now been superseded by an updated page on this website that can be found here: http://www.diabettech.com/looping-a-guide/comparing-the-loop-and-openaps-algorithms/
Port and Portability – form and physicality of the closed loop
With a nod to the nineties, thank you Mr Curtis and Mr Elton, and some sweet alliteration, my tramping around with a veritable “pancreas farm” […]
Diabetes Tech is a revelation, but what do we do when it breaks? Treatment Continuity Planning…
I’ve been closed looping now since September, so I’m coming up to my three months anniversary, and I couldn’t be happier. It’s the lowest variance […]
Abbott’s #FreestyleLibre – disrupting and democratising Diabetes care in Europe
A little over two years ago, the Abbott Freestyle Libre launched, to much fanfare and significant consumer trialling and direct patient marketing (anyone see a […]